ERBB2 and breast carcinoma: Furthermore, our systematic interrogation of these tumors contradicts the heterogeneous staining observed with established IHC and FISH clinical markers for ER, PR and ERBB2 and highlights the variety of fixed and shared genomic lesions in these three distinct breast cancer cases.